Show results for
Refine by
Clinical Study Suppliers In Poland
6 companies found
based inGliwice, POLAND
EGZOTech is the producer of Luna EMG - a rehabilitation robot for neurological and orthopedic patients! Luna provides force feedback and can use bioelectric signals to help patients with muscle atrophy (e.g. Duchenne's muscle atrophy, spinal muscle ...
based inKraków, POLAND
Instytut Biotechnologii Surowic i Szczepionek BIOMED Spółka Akcyjna is a Polish biotechnological company combining modernity with tradition. We manufacture biological medications (biologicals), in particular specific and non-specific bacterial ...
based inLublin, POLAND
We are a Polish biotechnology company with long manufacturing traditions. We have been present on the Polish and international markets since 1944. We are challenged and truly honoured to provide the leading, innovative medical solutions, and, due to ...
based inBillerica, MASSACHUSETTS (USA)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists ...
based inBridgend, UNITED KINGDOM
Markes (a Velaris brand) is a world-leading developer of technologies that enhance the analytical power of GC for both routine & research work. Its award-winning thermal desorption & automated sample extraction/concentration systems enable highly ...
Markes’ BioVOC-2™ breath sampler is a lightweight and simple-to-use device designed for non-invasive biological exposure monitoring of VOCs. Using a design pioneered by the UK Health & Safety Executive, BioVOC-2 collects the last 129 ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Colorectal cancer (CRC) is the second-most common cancer diagnosed in women and third-most in men. Based upon five-year survival rates, chances of becoming cured remain to be approximately 65%. Therapies targeting immunological checkpoints, or more ...
